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Overview 
1. Control strategies of FMD 
2. Vaccination as a control strategy. Why use this method (Advantages and disadvantages)? 
3. Vaccination strategies 
4. Available FMD vaccines 
5. Vaccine selection for a particular region? How to determine a vaccine to use 
6. Period of vaccination in a herd (how long is the protection) 
7. Revaccination 
8. Possible failures in FMD vaccination 
FMD – Essential info 
• Viral disease of “Cloven hoofed animals” 
 
 
 
• Picornavirus - 7 serotypes 
• High morbidity - low mortality 
 
FMD direct impact 
• Highly infectious 
– Ro 2–70 (depending on the setting)      
– High attack rate in outbreaks (>70%) 
– Repeated outbreaks affecting many animals 
– Rapid spread 
– 3-5 day incubation & pre-infectious period 
– UK 2001 - >56 farms infected before disease detected  
• Reduced productivity 
– Especially commercial dairy 
– Prevents use of high productivity breeds 
– Reduced traction (beasts of burden) 
FMD indirect impact 
• Trade restrictions 
– FMD free countries block imports from FMD 
affected countries/zones 
• Disastrous for exporting countries 
– Cost of control 
• Movement/trade restrictions 
– May discourage reporting 
• Vaccination (only measure in most endemic countries) 
• Culling & compensation 
» Impact on other industries (tourism) 
 
Upper panel – August 2014, OIE global FMD 
status, with recent outbreaks in free zones 
identified. 
 
Middle panel - global burden of FMD in cattle in 
2008 (burden in sheep and goats has a similar 
distribution). Prevalence index based on 
estimates of incidence, population distribution 
and other risk factors, adapted from (Sumption, 
Rweyemamu et al. 2008). Note progress in South 
America since 2008 [compare with upper panel]. 
 
Lower panel - density of poor rural livestock 
keepers from (Thornton, Kruska et al. 2002). 
Central America, parts of South East Asia and 
some areas in South America are the few 
exceptions where FMD was not present in poor 
livestock keeper populations. 
FMD conjectured status and serotypes 
Paton et al. (2009) 
Control measures 
a) Movement restrictions 
a) Close markets 
b) Between farms, zones, … 
c) Wildlife 
b) Other biosecurity 
a) Fomite control 
b) Vector control (people, insects, objects,….) 
c) Cleaning and disinfection of affected premises 
d) Culling (affected, dangerous contacts,…) 
e) Vaccination 
a) Mass vaccination 
b) Targeted vaccination 
a) Ring/reactive vaccination 
b) Zonal (Cordon Sanitaire) 
c) Specific risk group 
c) Private verses public funded vaccination 
 
• Use of control zones – see Botswana, South Africa 
 
• Which measures reduce exposure and which reduce susceptibility? 
Lancisi 1711 
http://post.queensu.ca/~forsdyke/rindpst0.htm 
FMD vaccines 
• Inactivated 
• Serotype specific protection 
– Variation in protection between strains within serotype 
– Multivalent vaccines used 
• Short duration (<6 months?)  
– from serology & challenge studies 
• Repeated vaccination throughout life 
• Two dose 30 days apart primary course 
– Important but often not given 
• Poor stability (3-8ºC) 
• Sometimes can distinguish infected from 
vaccinated+uninfected – NSP purified vaccines 
• Non-Structural Protein (NSP) serology 
 
Approximate global FMD vaccination 
Used to eradicate FMD from Europe (1991-92) 
 
 
Region Million doses/Year Comments 
China 1.6 billion doses 5 government producers 
South America 500 Brazil: 350 million doses 
Asia (excluding China) 200 India: 150 million doses 
Middle East 20 
European region 20 Mainly Turkey 
Africa 15 Hamond (2010) 
What are the advantages and disadvantages 
of using vaccination to control FMD? 
Vaccination 
• Vaccination based control: 
– Advantages 
• May not need to cull 
• Protection even if cannot apply other control measures to reduce virus exposure 
• Sounds simple! 
– Disadvantages 
• Short duration of immunity 
• Limited spectrum of protection 
• Population turnover – young are highly susceptible 
• Cost – who pays? 
• Ongoing protection needed 
• False sense of security-affects risk behaviour 
• Vaccine quality/vaccine match 
• Coverage – herd immunity needed 
• Probably need biosecurity as well 
• Incentives for continued vaccination when not working 
• Needs thorough evaluation 
• Logistics of vaccinating million of livestock 
• Strain on veterinary services 
• Top down approach – inconsiderate of field situation needs of farmers 
• Mask infection/transmission – carriers 
• Affects ability to prove disease freedom 
• Affects trading restrictions if free but vaccinate 
 
 
 
Current evaluation methods 
• Vaccine protection: 
– Challenge studies – PD50, PPG 
• Small numbers 
• Unnatural challenge 
– In vitro serological vaccine matching studies 
• r-values, Expected percentage protection 
• Do not actually assess if animals are protected 
– Sero-surveys 
• To assess post-vaccinal antibody response 
• Population immunity (Structural Protein [SP] titre) 
– With antibody titre as a correlate of protection 
– Cannot tell if sero-positive from natural infection or vaccination 
» High sero-prevalence =good or bad vaccination programme 
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r-value matching test 
Current evaluation methods 
• Sero-prevalence surveys as indicator of burden 
• Vaccine protection: 
– Serological correlate of protection 
• Limited protection against different serotypes/strains 
• New strains appear frequently 
• Vaccine coverage: 
– Distributed method 
• Number of doses distributed/Estimated population size 
• Vaccination programme impact 
– ? 
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Protection in the field may vary 
Cold chain 
Shelf life 
Batch variability 
Variable animal response 
Field protection: 
protection that counts 
Match with field virus 
Time since last vaccinated 
Number of doses in lifetime 
Level/duration of virus exposure 
FMD vaccine evaluation 
Challenge 
studies 
in vitro 
matching 
assays 
Post-
vaccination 
serology 
Vaccine 
effectiveness 
Other… 
1. Are vaccinated animals protected? 
 
 
2. Are the animals being vaccinated (adequately)? 
  
Key questions for a vaccination programme: 
 
 Vaccine effectiveness 
 
 
 Vaccine coverage 
Vaccine coverage… questions 
• What levels of coverage are achieved? 
– Are there important groups of under-vaccinated 
stock? 
• How does coverage vary over the annual 
production cycle? 
– Considering population turnover 
– How does this relate to key epidemiological 
events? 
• Spring turn out to grazing 
• Times of mass trading & livestock movements 
 
Reduction in risk in similarly exposed vaccinated 
compared to unvaccinated animals in the field 
 
 
Vaccine effectiveness 
  
FMD vaccine studies in Turkish cattle 
 
 
22 
FMD vaccine protection: 
- Requires several doses (≥3PD50) 
- Declines with time since vaccination 
Mass vaccination 
 Mass vaccination 
Population immunity ≈ Population vaccination history 
 [No. of doses, time since last dose] 
Population vaccine history ≈ Population age structure 
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Mass vaccination twice a year: 
  Population age-sex-vaccination distribution 
 
Beef suckler cattle: 
Percentage of population 
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Mass vaccination twice a year: 
  Population age-sex-vaccination distribution 
 
 
Beef fattener 
cattle: 
9-10 
doses 7-8 doses 
5-6 doses 
Age Females 
4-5 years 
 
3-4 years 
 
2-3 years 
 
1-2 years 
 
0-1 years 
Males 
Percentage of 
population 
Females 
Different production system = different age structure = different population immunity 
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Population vaccine history & immunity varies by region 
26 
Structure changes with births & deaths 
over the annual production cycle  
New births = New unvaccinated animals 
Population immunity is constantly changing with 
population turnover & declining antibodies 
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Post-vaccination immunity also declines with time 
Vaccinated 
Spring+Autumn 
2012 
Vaccinated 
Autumn 2011+ 
Spring+Autumn 
2012 
Protection 
threshold once twice 3 times 
2.3 
2.4 
2 
0 
Log10 (SP titre) 
Autumn mass 
vaccination 
Vaccinated 
 Autumn 2012 
depending vaccine history 
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If 3 doses needed for “adequate” protection 
If multiple doses needed, variation in immunity resulting 
from variation in coverage becomes exaggerated 
District with 100% coverage: 
After 3 rounds: 100% of  cattle vaccinated 3 times 
District with 50% coverage: 
After 3 rounds: 50% x 50% x 50% = 12.5% vaccinated 3 times 
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Population coverage model 
• Describe population immunity over the production 
cycle with 2012 Turkish mass vaccination policy 
• Simulated the Turkish cattle population for each 
province 
• Age-structure by day and month of birth 
• Using data from national random surveys for each province and census data 
 
 
• Dynamic population model representing the changing age 
structure for each province over the annual production cycle 
30 
31 
32 
Küçükkalecik 
Işıklar 
1 2 
3 4 
3 
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Percentage never vaccinated 6 months after mass vaccination 
 – if eligible cattle always vaccinated 
Unvaccinated = Cattle too young at prior vaccination 
+ 
New births since prior vaccination 
median values reported 
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Vaccinated ≥3 times  = Adult cattle 
Percentage vaccinated ≥3 times in lifetime 
 – if eligible cattle always vaccinated 
36 
Field studies and routine data found 40–99.9% vaccinated 
But not all eligible cattle will be vaccinated 
Results: 
 
• Six months after the last round of vaccination almost 
half of the cattle aged ≤24 months remain unvaccinated 
Betapert distribution (minimum=40%, maximum=100%, most likely=80%)  
• Only 50% of all cattle would have been vaccinated more 
than once with the last dose received ≤6 months ago 
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• Using regression models fitted to data from 
extensive post-vaccination sero-monitoring study 
[n=647] 
• Predict immunity for simulated population 
 
LPBE SP titre = Time since vaccination + No. of times vaccinated 
From coverage to immunity 
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Population immunity predictions 
Primary course Autumn mass 
vaccination 
Two-dose primary course: 
Increases proportion of 
 6-12 month cattle above 
threshold by 25-40% 
 
Log10 (SP titre) ≥2:    32% [25%-40%] 
Log10 (SP titre) ≥ 2: 27% [20%-35%] 
Log10 (SP titre) ≥ 2: 30% [24%-38%] 
Log10(SP titre) 
Threshold titre is useful but 
Titre ≈ Protection 
Antigenic similarity of: 
1) Vaccine – 2) Test – 3) Field virus 
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District coverage and population immunity 
Modelled proportion vaccinated in a district at autumn vaccination against the percentage 
of cattle with a serotype O SP titre ≥1:102 in mid February 
40 
Sustained antibodies after single dose 
From: Selman P, Chénard G, Dekker A (2006) Cedivac-FMD; Duration of Immunity in 
cattle, sheep and pigs. Open session of the EuFMD, Paphos, Cyprus, 17-19 October 2006  
Immunity reflects coverage 
Fewer problems  
41 
• Major immunity gaps despite biannual mass vaccination 
 
• Improved vaccine required 
• ≥6PD50 vaccine now routine in Turkey 
• Two-dose primary course used in certain areas 
 
• Immunity gaps will still exist 
• Each round of vaccination may exclude a quarter of all cattle 
• Often unavoidable 
 
• Improved biosecurity measures required 
• Avoid over reliance on vaccine protection 
 
Conclusions: Mass vaccination in Turkey 2012 
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What are they? 
Possible reasons for failures in FMD vaccination 
programme? 
 
Vaccine programme evaluation 
Potent 
vaccine 
Potent 
vaccine 
Vaccine 
coverage 
Field 
Protection   
 
 
Pre-field 
application 
In the field 
Why is FMD control so challenging? 
• Highly infectious with rapid transmission 
• Multispecies including wildlife 
• Multiple serotypes with variation within serotypes 
• Some farmers/regions lack motivation to control FMD  
• Vaccines: 
– Short lived protection against limited range of strains 
– Expensive & unstable (cold-chain required) 
• Subclinical infections 
• Livestock population turnover & movements 
• Cost/impact of control measures 
 
